Exane Derivatives’s Karuna Therapeutics KRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding KRTX
Exane Derivatives's KRTX Position: Q2 2022 in Review
Exane Derivatives held its Karuna Therapeutics (KRTX) position steady in Q2 2022 at 740 shares worth $93.6K. The position accounts for 0.05% of the portfolio, ranked #270.
Exane Derivatives first reported a position in KRTX in Q4 2021 and has held it in 3 quarters since. The position peaked at $105K in Q4 2021. 195 funds tracked by Wall St. Rank hold KRTX as of Q2 2022.
- Exane Derivatives held 740 shares of Karuna Therapeutics worth $93.6K as of Q2 2022.
- Exane Derivatives left its Karuna Therapeutics share count unchanged in Q2 2022.
- Karuna Therapeutics made up 0.05% of Exane Derivatives's portfolio in Q2 2022, its #270 holding.
- Exane Derivatives first reported a position in Karuna Therapeutics in Q4 2021 and has held it in 3 quarters since.
- Exane Derivatives's Karuna Therapeutics position peaked at $105K in Q4 2021.
- 195 funds tracked by Wall St. Rank held Karuna Therapeutics as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.